Index
-
Market Cap
227.72M
Enterprise Value
273.66M
Income
-31.96M
Sales
96.10M
Book/sh
0.90
Cash/sh
2.48
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
334
IPO
Oct 28, 2020
P/E
-
Forward P/E
-
PEG
-
P/S
2.37
P/B
24.34
P/C
8.87
P/FCF
-
EV/EBITDA
-
EV/Sales
2.85
Quick Ratio
2.72
Current Ratio
2.82
Debt/Eq
7.84
LT Debt/Eq
7.68
Option/Short
No / Yes
EPS (ttm)
-4.03
EPS next Y
-1.77
EPS next Q
-0.90
EPS this Y
36.71%
EPS next Y
40.26%
EPS next 5Y
39.19%
EPS past 3/5Y
46.84% 27.68%
Sales past 3/5Y
32.31% 14.20%
EPS Y/Y TTM
29.88%
Sales Y/Y TTM
29.05%
EPS Q/Q
46.73%
Sales Q/Q
42.30%
Insider Own
55.01%
Insider Trans
3.10%
Inst Own
38.73%
Inst Trans
39.80%
ROA
-35.34%
ROE
-316.53%
ROIC
-40.30%
Gross Margin
82.08%
Oper. Margin
-25.91%
Profit Margin
-33.26%
SMA20
21.66%
SMA50
41.96%
SMA200
93.38%
Trades
Shs Outstand
10.11M
Shs Float
4.66M
52W High
24.92 -11.74%
52W Low
5.26 318.06%
Volatility
12.29% 9.12%
ATR (14)
1.86
RSI (14)
63.56
Beta
0.54
Rel Volume
0.85
Avg Volume
74.05K
Volume
62,605
Perf Week
9.73%
Perf Month
42.42%
Perf Quarter
48.98%
Perf Half Y
227.23%
Perf YTD
223.38%
Perf Year
299.82%
Perf 3Y
-10.61%
Perf 5Y
-90.96%
Perf 10Y
-
Prev Close
24.50
Price
21.99
Change
-10.24%
Date
Action
Analyst
Rating Change
Price Target Change
Jun-25-26 Initiated Roth Capital
Buy
$32
Jun-15-26 Initiated H.C. Wainwright
Buy
$26
Feb-27-26 Upgrade William Blair
Mkt Perform → Outperform
May-14-25 Downgrade William Blair
Outperform → Mkt Perform
Sep-16-24 Initiated Scotiabank
Sector Outperform
Jul-26-24 Initiated Craig Hallum
Buy
$3
May-13-24 Initiated TD Cowen
Buy
$2.80
May-03-24 Initiated Lake Street
Buy
$3
Nov-17-21 Downgrade Morgan Stanley
Overweight → Equal-Weight
$21 → $11
Nov-23-20 Initiated William Blair
Outperform
Nov-23-20 Initiated Morgan Stanley
Overweight
$20
Nov-23-20 Initiated Canaccord Genuity
Buy
$26
Nov-23-20 Initiated BTIG Research
Buy
$22
Show Previous Ratings
May-21-26 06:00AM
May-11-26 09:17AM
May-04-26 08:16PM
04:01PM
May-01-26 09:19AM
12:33PM
Loading…
Apr-23-26 12:33PM
Apr-20-26 06:00AM
Apr-09-26 01:19PM
Apr-06-26 11:43AM
Mar-20-26 08:06AM
Mar-06-26 07:38AM
Mar-03-26 09:55AM
09:40AM
Feb-27-26 12:04AM
Feb-26-26 05:48PM
05:15PM
Loading…
05:15PM
04:01PM
Feb-25-26 07:42AM
Feb-24-26 06:00AM
Feb-12-26 06:00AM
Jan-31-26 08:15AM
Jan-12-26 06:00AM
Dec-24-25 01:48PM
Dec-19-25 11:05AM
Dec-03-25 09:55AM
08:22AM
Nov-04-25 12:01AM
Nov-03-25 05:30PM
04:01PM
Oct-31-25 09:35AM
06:17AM
Loading…
Oct-30-25 06:17AM
Oct-29-25 05:45PM
Oct-27-25 07:10AM
Oct-22-25 06:17AM
Oct-20-25 06:00AM
Oct-15-25 06:09AM
Oct-06-25 10:13AM
Sep-11-25 08:00AM
Sep-05-25 06:00AM
Sep-04-25 10:30AM
(Associated Press Finance)
+5.05%
Aug-19-25 09:47AM
Aug-07-25 05:20PM
04:06PM
Aug-05-25 06:00AM
Aug-01-25 07:15AM
Jul-25-25 12:22PM
12:22PM
Jul-24-25 06:00AM
Jun-10-25 06:17AM
May-22-25 05:03PM
May-21-25 06:00AM
May-15-25 06:00AM
May-14-25 04:01PM
03:16AM
May-13-25 05:15PM
04:01PM
May-12-25 09:50AM
09:25AM
May-08-25 06:30PM
Apr-30-25 07:45AM
Apr-29-25 06:00AM
Apr-28-25 07:15AM
Apr-25-25 07:15AM
Apr-23-25 06:00AM
Mar-06-25 12:00PM
Mar-04-25 05:20AM
02:03AM
Mar-03-25 04:01PM
Feb-28-25 07:15AM
Feb-26-25 06:00AM
Feb-18-25 06:00AM
Jan-10-25 06:00AM
Jan-07-25 06:00AM
Nov-20-24 09:35AM
Nov-02-24 03:01AM
Nov-01-24 07:15AM
06:00AM
Oct-31-24 09:06AM
Oct-29-24 06:00AM
Oct-18-24 06:00AM
Oct-07-24 06:00AM
Sep-05-24 06:00AM
Aug-08-24 10:23AM
(Thomson Reuters StreetEvents)
Aug-07-24 06:05PM
04:01PM
Aug-06-24 06:00AM
Jul-24-24 06:00AM
Jun-18-24 08:13AM
May-28-24 06:00AM
May-21-24 06:00AM
May-10-24 05:59PM
03:55PM
May-09-24 03:46AM
May-08-24 09:00PM
05:20PM
04:01PM
May-07-24 06:00AM
Apr-24-24 06:00AM
Apr-09-24 05:00PM
Apr-05-24 07:17AM
Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.
President Mr. Scott Hutton
CFO Ms. Robin Harper Cowie
Chief Commercial Officer Mr. Kieran O'Kane
Founder & CTO Dr. Heinrich Roder D.Phil
Chief Scientific Officer Dr. Gary Anthony Pestano Ph.D.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Pestano Gary Anthony Chief Development Officer Feb 23 '26 Sale 12.78 556 7,103 10,359 Feb 23 08:22 PM O'Kane Kieran Chief Commercial Officer Feb 23 '26 Sale 12.78 535 6,835 9,819 Feb 23 08:22 PM Cowie Robin Harper CFO, Sec'y & Treasurer Feb 23 '26 Sale 12.78 535 6,835 16,231 Feb 23 08:22 PM Vazquez Chris Chief Accounting Officer Feb 23 '26 Sale 12.78 211 2,696 1,586 Feb 23 08:22 PM Hutton Scott President & CEO Feb 23 '26 Sale 12.78 1,490 19,036 48,767 Feb 23 08:22 PM Hutton Scott Officer Feb 23 '26 Proposed Sale 12.77 1,490 19,027 Feb 23 08:22 PM O'Kane Kieran Chief Commercial Officer Feb 10 '26 Sale 10.08 584 5,889 8,885 Feb 11 06:03 PM Vazquez Chris Chief Accounting Officer Feb 10 '26 Sale 10.08 101 1,018 1,234 Feb 11 06:03 PM Hutton Scott President & CEO Feb 10 '26 Sale 10.08 3,559 35,889 45,413 Feb 11 06:03 PM Cowie Robin Harper CFO, Sec'y & Treasurer Feb 10 '26 Sale 10.08 941 9,489 15,297 Feb 11 06:03 PM Pestano Gary Anthony Chief Development Officer Feb 10 '26 Sale 10.08 540 5,445 9,387 Feb 11 06:03 PM SCHULER JACK W Emeritus Director Jan 23 '26 Buy 11.81 80,000 944,672 1,543,210 Jan 27 09:29 AM SCHULER JACK W Emeritus Director Jan 26 '26 Buy 11.80 20,000 236,064 1,563,210 Jan 27 09:29 AM SCHULER JACK W Emeritus Director Jan 22 '26 Buy 10.96 82,465 903,561 1,463,210 Jan 26 09:28 AM Vazquez Chris Chief Accounting Officer Jan 16 '26 Sale 8.15 83 676 1,072 Jan 20 04:22 PM Pestano Gary Anthony Chief Development Officer Jan 16 '26 Sale 8.15 298 2,428 8,446 Jan 20 04:21 PM O'Kane Kieran Chief Commercial Officer Jan 16 '26 Sale 8.15 298 2,428 7,869 Jan 20 04:21 PM Hutton Scott President & CEO Jan 16 '26 Sale 8.15 970 7,905 38,974 Jan 20 04:21 PM Cowie Robin Harper CFO, Sec'y & Treasurer Jan 16 '26 Sale 8.15 298 2,428 13,654 Jan 20 04:21 PM Vazquez Chris Chief Accounting Officer Nov 10 '25 Sale 7.62 13 99 936 Nov 13 04:54 PM Pestano Gary Anthony Chief Development Officer Nov 10 '25 Sale 7.62 23 175 7,939 Nov 13 04:54 PM O'Kane Kieran Chief Commercial Officer Nov 10 '25 Sale 7.62 25 190 7,362 Nov 13 04:53 PM Hutton Scott President & CEO Nov 10 '25 Sale 7.62 189 1,440 37,311 Nov 13 04:53 PM Cowie Robin Harper CFO, Sec'y & Treasurer Nov 10 '25 Sale 7.62 50 381 13,147 Nov 13 04:53 PM SCHULER JACK W Director Sep 19 '25 Buy 7.04 142,045 999,997 1,380,745 Sep 23 09:29 AM SCHULER JACK W Director Sep 17 '25 Buy 6.04 15,317 92,571 1,235,644 Sep 19 10:31 AM SCHULER JACK W Director Sep 18 '25 Buy 6.17 3,056 18,854 1,238,700 Sep 19 10:31 AM SCHULER JACK W Director Aug 29 '25 Buy 0.43 3,488,372 1,500,000 24,406,546 Sep 03 04:42 PM Cowie Robin Harper CFO, Sec'y & Treasurer Aug 13 '25 Sale 0.42 988 411 250,794 Aug 14 05:25 PM Hutton Scott President & CEO Aug 13 '25 Sale 0.42 3,772 1,570 728,824 Aug 14 05:25 PM O'Kane Kieran Chief Commercial Officer Aug 13 '25 Sale 0.42 476 198 140,065 Aug 14 05:24 PM Pestano Gary Anthony Chief Development Officer Aug 13 '25 Sale 0.42 442 184 157,878 Aug 14 05:24 PM Vazquez Chris Chief Accounting Officer Aug 13 '25 Sale 0.42 228 95 18,375 Aug 14 05:24 PM
